Damiano Calvo
University of Catania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Damiano Calvo.
Future Oncology | 2015
Marcello Migliore; Damiano Calvo; Alessandra Criscione; cristina Viola; Giuseppe Privitera; Corrado Spatola; Hector Soto Parra; Stefano Palmucci; Nicola Ciancio; Rosario Caltabiano; Giuseppe Di Maria
Cytoreductive surgery and hyperthermic-intraoperative-intrapleural-chemotherapy (HITHOC) is a known approach for malignant pleural diseases (MPD). This study was started to clarify the role of cytoreductive surgery and HITHOC in MPD. Criteria of inclusion were early-stage disease in malignant pleural mesothelioma (MPM), young age, good condition and selected stage-M1a lung cancer. Six patients with MPM and two patients with lung cancer were enrolled. After surgical debulking, intrapleural cisplatin was administered for 60 min at 42.5°C. Wedge, rib resection and repaired diaphragm were added in three, one and one patient, respectively. Morbidity, toxicity and mortality was nil. Hospital stay was 8 days. Mean survival is 13.6 months. This experience confirms that cytoreductive surgery and HITHOC is a good option in the treatment of MPD. A randomized controlled trial is necessary.
Future Oncology | 2015
Marcello Migliore; Alessandra Criscione; Damiano Calvo; Francesco Borrata; Mariapia Gangemi; Giorgio Attinà
As part of the Second Catania Symposium on Thoracic Oncology, as we started the experience with video-assisted thoracic surgery (VATS) lobectomy for lung malignancies, we reviewed our data and argued some comments in a more general discussion. Operated patients with non-small-cell lung cancer were divided in two groups and compared: VATS (collected in a prospective database) and open (historical group). Out of 74 patients, 31 in group A and 44 in group B. The majority of patients in group A were stage I-II. Mean operative time was shorter in group A. Postoperative hospital stay was shorter in group A. There was no mortality. VATS is effective and safe to perform pulmonary lobectomy in our unit, and it represents our preferred approach for early-stage lung cancer.
Case Reports | 2013
Alessandra Criscione; Adriana Scamporlino; Damiano Calvo; Marcello Migliore
Intrapulmonary bronchogenic cysts (IBC) represent 20% of abnormal budding of the respiratory tract. Lobectomy is the recommended treatment for IBC in symptomatic adults. We presented a case of a patient with an IBC involving the right upper and middle lobes (RUL–RML). A 27-year-old woman presented with a 2-month history of thoracic pain, cough and haemoptysis. An opacity was found on the chest X-ray. High-resolution CT/MRI showed a 7×4.5 cm marginated mass with an air bubble inside. A video-assisted thoracoscopic surgery was performed. The cyst was neither palpable nor visible. An intraoperative ultrasonography localised the cyst involving the RUL–RML. The lung above the cyst was incised, and a greenish-mucoid content was aspirated. A branch of the superior pulmonary vein was visible. The remaining cystic wall was cauterised. The patient was discharged on day 4. Histology confirmed the IBC. The patient is asymptomatic at a 16-month follow-up. The lung-sparing operation in a young woman with IBC involving the RUL–RML has been beneficial. A long-term follow-up is mandatory.
Future Oncology | 2015
Corrado Spatola; Marcello Migliore; Rocco Luca Emanuele Liardo; Roberta Bevilacqua; Raffaele Luigi; Salamone Vincenzo; Alessandra Tocco; Antonio Pagana; Carmelo Militello; Damiano Calvo; Alessandra Criscione; Giuseppe Privitera
Follicular dendritic cell sarcoma is a rare and aggressive tumor and its management is a major clinical challenge. Surgery is considered the mainstay of treatment and no adjuvant approach has demonstrated the ability to reduce the rate of relapses. We report on a case of a man with a 26-year clinical history of mediastinal follicular dendritic cell sarcoma, with several relapses after multiple surgical interventions. The impact of chemotherapy was very small, unlike the radiation therapy that was performed twice, with an interval time of 8 years, through an intensity-modulated technique and an altered fractionation schedule.
Future Oncology | 2015
Marcello Migliore; Damiano Calvo; Alessandra Criscione; Stefano Palmucci; Giovanni Fuccio Sanzà; Rosario Caltabiano; Corrado Spatola; Giuseppe Privitera; Marco Maria Aiello; Hector Soto Parra; Nicola Ciancio; Giuseppe Di Maria
Cytoreductive surgery and hyperthermic intraoperative intrapleural chemotherapy (HITHOC) are a known option for malignant pleural mesothelioma (MPM). This prospective study was started to prove that pleurectomy/decortication and HITHOC could be successfully performed in a low volume center. Criteria of inclusion were a proven diagnosis of MPM, early-stage disease and good performance status. Six consecutive patients were enrolled. After pleurectomy/decortication, intrapleural cisplatin was administered for 60 min at 42.5 °C. Wedge resections and diaphragmatic reconstruction were added in two and one patient, respectively. Morbidity was 16.6%. Mortality was nil. Hospital stay was 7.8 days. Mean survival was 21.5 months (range: 6-30). This small experience confirms that pleurectomy/decortication and HITHOC are a good therapeutic option in the multimodality treatment of MPM. A randomized controlled trial is necessary.
Asian Cardiovascular and Thoracic Annals | 2014
Marcello Migliore; Valerya Okateya; Damiano Calvo; Alessandra Criscione; Borrata Francesco
Solitary fibrous tumors of the pleura are rare intrathoracic neoplasms, especially in the giant form. The treatment of choice remains complete surgical resection which provides a benign clinical outcome. All patients need long-term follow-up due to the possibility of late recurrences. We describe 2 new cases of giant pleural fibrous tumor, which underwent resection via thoracotomy, and discuss the diagnostic and therapeutic modalities.
Updates in Surgery | 2013
Marcello Migliore; Alessandra Criscione; Damiano Calvo; Tom Routledge
Anterior mediastinotomy and VATS are today the most common surgical approaches to obtain tissue diagnosis or to remove mediastinal lesions. However, both methods lead to inconveniences. This report demonstrates the advantages of a minimal access mediastinotomy to remove or diagnose mediastinal lesions.
Future Oncology | 2015
Alessandra Criscione; Stefano Palmucci; Damiano Calvo; Gaetano Magro; Maria Coronella; Marina Piccoli; Maria Letizia Lanza; Federica Roccasalva; Rosario Caltabiano; Guido Basile; Marcello Migliore
A total of 13 patients (11 females, average age of 63 years) with elastofibromadorsi were retrospectively analyzed. The disease was confirmed by surgical intervention in five cases. In other patients (n = 8) the diagnosis was achieved on the basis of clinical and radiological features. Typical imaging features allow for the diagnosis of elastofibromadorsi. Symptomatic lesions need to be surgically removed, whereas asymptomatic ones could be clinically and radiologically monitored.
Case Reports | 2013
Marcello Migliore; Mariapia Gangemi; Damiano Calvo; Stefano Palmucci
A 42-year-old man presented with productive cough, haemoptysis, night sweating, temperature 39°C, asthenia and weight loss of 35 kg in 12 months. He had a 25-year history of smoking (40 cigarettes/day) and alcoholism. Laboratory tests showed normochromic normocytic anaemia (haemoglobin 8.8 g/dL, red blood cell 2.72×106/mmc, and mean corpuscular volume 100), neutrophilic leucocytosis and white cell count 17 78×103/mmc). Chest CT scan revealed an excavated lesion in the apico-dorsal segment of the left upper lobe (65×70 mm) with solid vegetation inside, delimitated by a thick wall with polylobate edges, and the suggestive presence of …
Annali Italiani Di Chirurgia | 2014
Marcello Migliore; Damiano Calvo; Alessandra Criscione; Rosario Caltabiano; Nunzio Platania; Giuseppe Barbagallo; Albanese